Вход на сайт
Просмотр новости

Найдите то, что Вас интересует

Pathological response and exploratory assessment of pretreatment PD-L1 combined positive score after four cycles of neoadjuvant pembrolizumab plus chemotherapy in locally advanced head and neck squamous cell carcinoma: a retrospective cohort study
Дата публикации: 07-08-2026 14:10:42

An article created on 2026-08-07 14:10:42

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Longitudinal intratumoral and peritumoral MRI radiomics for predicting pathologic complete response to neoadjuvant chemoimmunotherapy in locally advanced head and neck squamous cell carcinoma: a retrospective two-center study015.2820-10-2026
2Evaluation of the Relationship between Carcinoma-Associated Fibroblasts and Cancer Stem Cells in Oropharyngeal Squamous Cell Carcinoma019.0910-08-2026
3Pretreatment Neutrophil-to-Lymphocyte Ratio in Endometrial Cancer: Association with Adverse Pathology and Advanced Stage but Not Overall Survival — A Single-Centre Cohort Study020.7107-08-2026
4Superselective intra-arterial cisplatin infusion and concomitant radiotherapy (RADPLAT) for maxillary sinus squamous cell carcinoma: an institutional experience of 118 cases020.3410-08-2026
5Pembrolizumab Plus Quad-Shot Radiotherapy for Recurrent, Unresectable, or Metastatic Head and Neck Cancer08.6401-08-2026
6Combined Furmonertinib and Intrathecal Chemotherapy for Leptomeningeal Metastasis from Non-Small Cell Lung Cancer: Efficacy, Safety, and CSF Drug Concentrations016.907-08-2026
7Larger Mesorectal Fat Area Predicts Better Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer：A Real-World Retrospective Study018.3310-08-2026
8Weight Loss Despite Nutritional Support Predicts Poor Outcomes After Postoperative Chemoradiotherapy for High-Risk Head and Neck Cancer018.710-08-2026
9Diagnostic Performance and Prognostic Value of Whole-Body 18F-FDG PET/CT in Patients with Carcinoma of Unknown Primary: A Prospective Cohort Study016.6410-08-2026
10Neoadjuvant camrelizumab plus chemotherapy versus chemotherapy alone for resectable esophageal squamous cell carcinoma: A Prospective Multicenter randomised controlled study013.0619-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 13.96. Источник: www.researchsquare.com.